More effective therapeutic targeting of high risk childhood cancer: Neuroblastoma as a model

癌症是澳大利亚儿童最常见的疾病死因。儿童神经母细胞瘤是一种侵袭性特别强的癌症，迫切需要新的治疗方法。该团队的目标是为患有这种癌症的儿童找到更好、更安全的治疗方法，使用新药和新的药物组合进行临床试验。我们还将研究以神经母细胞瘤细胞为靶点的新方法，并确定神经母细胞瘤启动细胞的治疗靶点。

Cancer is the commonest cause of death from disease in Australian children. Childhood neuroblastoma is a particularly aggressive cancer, for which new treatment approaches are urgently needed. The team aims to discover better safer therapies for children with this cancer, conducting clinical trials using new drugs and novel drug combinations. We will also investigate novel ways of targeting neuroblastoma cells and identify therapeutic targets in neuroblastoma-initiating cells.